Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years-Reference-Cited by-同舟云学术

Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years

Published:2023-06 Issue: Volume:250 Page:103-110
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Duncan Jacque L.^ORCID,Cheng Peiyao,Maguire Maureen G.^ORCID,Ayala Allison A.^ORCID,Birch David G.^ORCID,Cheetham Janet K.^ORCID,Durham Todd A.^ORCID,Fahim Abigail T.^ORCID,Hoyng Carel B.,Ishikawa Hiroshi^ORCID,Michaelides Michel,Pennesi Mark E.^ORCID,Sahel José-Alain,Stingl Katarina^ORCID,Weng Christina Y.

Funder

Foundation Fighting Blindness Inc

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial;Russell;Lancet,2017

2. Durability of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease: phase 3 results at 3 and 4 years;Maguire;Ophthalmology,2021

3. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials;Maguire;Ophthalmology,2019

4. Antisense oligonucleotide-based splice correction for USH2A-associated retinal degeneration caused by a frequent deep-intronic mutation;Slijkerman;Mol Ther Nucleic Acids,2016

5. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations;Dulla;Mol Ther,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, leber congenital amaurosis, and cone dysfunction syndromes;Progress in Retinal and Eye Research;2024-01